Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) FCF Margin (2016 - 2025)

Historic FCF Margin for vTv Therapeutics (VTVT) over the last 10 years, with Q4 2024 value amounting to 28382.35%.

  • vTv Therapeutics' FCF Margin changed N/A to 28382.35% in Q4 2024 from the same period last year, while for Sep 2025 it was 122523.53%, marking a year-over-year decrease of 1201839300.0%. This contributed to the annual value of 2488.4% for FY2024, which is N/A changed from last year.
  • vTv Therapeutics' FCF Margin amounted to 28382.35% in Q4 2024.
  • Over the past 5 years, vTv Therapeutics' FCF Margin peaked at 7844.44% during Q2 2022, and registered a low of 77628.57% during Q3 2020.
  • Over the past 4 years, vTv Therapeutics' median FCF Margin value was 14557.93% (recorded in 2024), while the average stood at 30109.08%.
  • As far as peak fluctuations go, vTv Therapeutics' FCF Margin skyrocketed by 839082900bps in 2020, and later crashed by -712654300bps in 2021.
  • vTv Therapeutics' FCF Margin (Quarter) stood at 34.57% in 2020, then crashed by -206161bps to 71300.0% in 2021, then dropped by -7bps to 76444.44% in 2022, then skyrocketed by 63bps to 28382.35% in 2024.
  • Its FCF Margin was 28382.35% in Q4 2024, compared to 733.5% in Q1 2024 and 76444.44% in Q4 2022.